FundedIQ
Biotechnology

Gramercy Extremity Orthopedics: Funding, Investors & Team (Sep 2026)

Gramercy Extremity Orthopedics is a medical device manufacturing company that specializes in providing inventory management, foot and ankle, implants, and product development. It features a proprietary RFID technology, Point-of-Sale delivery system, and sterilized single-use orthopedic implants and instruments. The company was founded in 2015 and headquartered in Texas, United States.

gramercyortho.com LinkedIn Richardson, United States 11-50 employees
Biotechnology Health Care Medical Device mHealth
Total raised
$9.8M
Rounds
1
Latest
Series A
Sep 2021

Gramercy Extremity Orthopedics has raised $9.8M across 1 funding round on record, the most recent a Series A of $9.8M announced in Sep 2021.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Gramercy Extremity Orthopedics Company Profile and Key Stats

Total funding raised
$9.8M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$9.8M in Sep 2021
Employees
11-50
reported band
Headquarters
Richardson, United States

Latest funding round on record: Sep 2021.

Gramercy Extremity Orthopedics Funding Rounds

Date
Round
Amount
Series A
$9.8M

Gramercy Extremity Orthopedics Founders and Leadership Team

Name
Role
Contact
Michael Simpson
CEO
Locked

Contact details for the Gramercy Extremity Orthopedics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Gramercy Extremity Orthopedics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M
8,422
$15M

Gramercy Extremity Orthopedics' latest round of $9.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Gramercy Extremity Orthopedics in Biotechnology and Richardson

Companies Similar to Gramercy Extremity Orthopedics

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Gramercy Extremity Orthopedics Funding FAQs

What does Gramercy Extremity Orthopedics do?

Gramercy Extremity Orthopedics is a medical device manufacturing company that specializes in providing inventory management, foot and ankle, implants, and product development. It features a proprietary RFID technology, Point-of-Sale delivery system, and sterilized single-use orthopedic implants and instruments. The company was founded in 2015 and headquartered in Texas, United States.

How much funding has Gramercy Extremity Orthopedics raised?

Gramercy Extremity Orthopedics has raised $9.8M across 1 round on record. The most recent is a Series A of $9.8M announced in Sep 2021.

When did Gramercy Extremity Orthopedics last raise funding?

Gramercy Extremity Orthopedics' most recent funding round on record is a Series A of $9.8M, announced in Sep 2021.

Who is the CEO of Gramercy Extremity Orthopedics?

Michael Simpson is listed as CEO at Gramercy Extremity Orthopedics.

Where is Gramercy Extremity Orthopedics headquartered?

Gramercy Extremity Orthopedics is based in Richardson, Texas, United States.

How many employees does Gramercy Extremity Orthopedics have?

Gramercy Extremity Orthopedics is in the 11-50 employee band.

How does Gramercy Extremity Orthopedics' funding compare to other Biotechnology startups?

Gramercy Extremity Orthopedics' latest round of $9.8M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's Gramercy Extremity Orthopedics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gramercy Extremity Orthopedics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.